Overview

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Status:
Completed

Trial end date:
2018-01-09

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in participants with nonalcoholic steatohepatitis (NASH).

Phase:

Phase 2

Details

Lead Sponsor:

Gilead Sciences